Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
The transforming growth factor-β (TGF-β) signalling pathway is a key mediator of fibroblast activation that drives the aberrant synthesis of extracellular matrix in fibrotic diseases. Here we demonstrate a novel link between transforming growth factor-β and the canonical Wnt pathway. TGF-β stimulates canonical Wnt signalling in a p38-dependent manner by decreasing the expression of the Wnt antagonist Dickkopf-1. Tissue samples from human fibrotic diseases show enhanced expression of Wnt proteins and decreased expression of Dickkopf-1. Activation of the canonical Wnt pathway stimulates fibroblasts in vitro and induces fibrosis in vivo. Transgenic overexpression of Dickkopf-1 ameliorates skin fibrosis induced by constitutively active TGF-β receptor type I signalling and also prevents fibrosis in other TGF-β-dependent animal models. These findings demonstrate that canonical Wnt signalling is necessary for TGF-β-mediated fibrosis and highlight a key role for the interaction of both pathways in the pathogenesis of fibrotic diseases. Aberrant activation of the TGF-β pathway leads to fibrotic disease. Distler and colleagues show that TGF-β-mediated fibrosis requires the decrease of Dickkopf-1, an antagonist of canonical Wnt signalling, suggesting that the two pathways interact for the manifestation of this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TGFβ signaling via p38 MAPK lowers dickkopf-1 (DKK1) expression (62), which is an inhibitor of canonical Wnt signaling via β-catenin. In skin and fibroblasts of SSc patients, decreased DKK1 expression is observed (62), together with increased β-catenin accumulation (63), and increased expression of Wnt signaling-related genes (62, 64).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [62]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Shi, Y., & Massagué, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00432-x · Cited by 5,857
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
The Wnt Signaling Pathway in Development and Disease
Logan, C. Y., & Nusse, R. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.010403.113126 · Cited by 5,325
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
Woessner, J. F. (1961) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(61)90291-0 · Cited by 3,840
Massagué, J., Seoane, J., & Wotton, D. (2005) · Genes & Development · doi:10.1101/gad.1350705 · Cited by 2,452
Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction
Glinka, A., Wu, W., Delius, H., Monaghan, A. P., Blumenstock, C., & Niehrs, C. (1998) · Nature · doi:10.1038/34848 · Cited by 1,608
Criteria for the classification of early systemic sclerosis.
LeRoy, E. C., & Medsger, T. A. (2001) · PubMed · Cited by 1,384
Gabrielli, A., Avvedimento, E. V., & Krieg, T. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0806188 · Cited by 1,384
Dickkopf-1 is a master regulator of joint remodeling
Diarra, D., Stolina, M., Polzer, K., Zwerina, J., Ominsky, M. S., Dwyer, D., Korb, A., Smolen, J., Hoffmann, M., Scheinecker, C., et al. (2007) · Nature Medicine · doi:10.1038/nm1538 · Cited by 1,298
Self-citation
Cited by
Items 101–200 of 873
Crosstalk between TGF-β and WNT signalling pathways during cardiac fibrogenesis
Działo, E., Tkacz, K., & Błyszczuk, P. (2018) · Acta Biochimica Polonica · doi:10.18388/abp.2018_2635 · Cited by 110
“Activation of the canonical WNT signalling in response to TGF-β and the functional contribution of this mechanism to fibrotic processes have been observed not only during cardiac fibrogenesis, but also in other organs, including skin (Akhmetshina et al., 2012), lungs (Xu et al.”
BackgroundCellular and molecular mechanisms in fibrosis
Dees, C., Chakraborty, D., & Distler, J. H. W. (2020) · Experimental Dermatology · doi:10.1111/exd.14193 · Cited by 121
Self-citationXu, L., Cui, W., Zhou, W., Li, D., Li, L., Zhao, P., Mo, X., Zhang, Z., & Gao, J. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13085 · Cited by 117
Global remodelling of cellular microenvironment due to loss of collagen VII
Küttner, V., Mack, C., Rigbolt, K. T. G., Kern, J. S., Schilling, O., Busch, H. S., Bruckner‐Tuderman, L., & Dengjel, J. (2013) · Molecular Systems Biology · doi:10.1038/msb.2013.17 · Cited by 115
“Moreover, TGF-b, a growth factor that stimulates expression of many ECM proteins (Akhmetshina et al, 2012), was increased in the CM of RDEB fibroblasts.”
Yan, J., Tung, H.-C., Li, S., Niu, Y., Garbacz, W. G., Lu, P., Bi, Y., Li, Y., He, J., Xu, M., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.05.066 · Cited by 107
TGFβ promotes fibrosis by MYST1-dependent epigenetic regulation of autophagy
Zehender, A., Li, Y., Lin, N., Stefanica, A., Nüchel, J., Chen, C., Hsu, H.-H., Zhu, H., Ding, X., Huang, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24601-y · Cited by 118
Self-citationDong, L.-H., Jiang, Y.-Y., Liu, Y.-J., Cui, S., Xia, C.-C., Qu, C., Jiang, X., Qu, Y.-Q., Chang, P.-Y., & Liu, F. (2015) · Scientific Reports · doi:10.1038/srep08713 · Cited by 103
Maier, C., Ramming, A., Bergmann, C., Weinkam, R., Kittan, N. A., Schett, G. A., Distler, J. H. W., & Beyer, C. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210189 · Cited by 116
Self-citationLiao, Z., Liu, C., Wang, L., Sui, C., & Zhang, H. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.665645 · Cited by 114
“org 4 stimulate TGF-b-mediated fibrosis and mediate fibrogenesis in the endometrium (65, 66).”
BackgroundJUN promotes hypertrophic skin scarring via CD36 in preclinical in vitro and in vivo models
Griffin, M., Borrelli, M. R., Garcia, J. T., Januszyk, M., King, M. E., Lerbs, T., Cui, L., Moore, A. L., Shen, A. H., Mascharak, S., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abb3312 · Cited by 111
Unfolding the pathogenesis of scleroderma through genomics and epigenomics
Tsou, P., & Sawalha, A. H. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.05.004 · Cited by 110
Muñoz-Castañeda, J. R., Rodelo‐Haad, C., de Mier, M. V. P.-R., Martín‐Malo, A., Santamaría, R., & Rodríguez, M. (2020) · Toxins · doi:10.3390/toxins12030185 · Cited by 105
“showed that canonical Wnt signaling activation is required for TGF-β-mediated fibrosis [57].”
BackgroundHeat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis
Tomčík, M., Zerr, P., Pitkowski, J., Palumbo‐Zerr, K., Avouac, J., Distler, O., Bečvář, R., Šenolt, L., Schett, G. A., & Distler, J. H. W. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-203095 · Cited by 111
Self-citationSvegliati, S., Marrone, G., Pezone, A., Spadoni, T., Grieco, A., Moroncini, G., Grieco, D., Vinciguerra, M., Agnese, S., Jüngel, A., et al. (2014) · Science Signaling · doi:10.1126/scisignal.2004592 · Cited by 100
Self-citationShentu, T., Huang, T.-S., Cernelc‐Kohan, M., Chan, J., Wong, S. S., Espinoza, C. R., Tan, C., Gramaglia, I., van der Heyde, H., Chien, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-18288-9 · Cited by 104
Maria, A. T. J., Partouche, L., Goulabchand, R., Rivière, S., Rozier, P., Bourgier, C., Quellec, A. L., Morel, J., Noël, D., & Guilpain, P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03112 · Cited by 106
“It repressed adipogenesis in subcutaneous pre-adipocytes, while inducing myofibroblast differentiation (115, 116).”
BackgroundMastrogiannaki, M., Lichtenberger, B. M., Reimer, A., Collins, C. A., Driskell, R. R., & Watt, F. M. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.01.036 · Cited by 98
“In addition, expression of the Wnt inhibitor Dkk1 interferes with profibrotic signaling (Akhmetshina et al., 2012).”
BackgroundAkcora, B. Ö., Storm, G., & Bansal, R. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.12.001 · Cited by 97
“In addition, we found activation of canonical Wnt signaling pathway with increased expression of βcatenin and increased transcription of target genes in activated HSCs and liver fibrosis as reported in organ fibrosis [25].”
BackgroundInfluentialVersican in inflammation and tissue remodeling: The impact on lung disorders
Andersson-Sjoland, A., Hallgren, O., Rolandsson, S., Weitoft, M., Tykesson, E., Larsson-Callerfelt, A.-K., Rydell-Tormanen, K., Bjermer, L., Malmstrom, A., Karlsson, J. C., et al. (2015) · Glycobiology · doi:10.1093/glycob/cwu120 · Cited by 98
Wakayama, H., Hashimoto, N., Matsushita, Y., Matsubara, K., Yamamoto, N., Hasegawa, Y., Ueda, M., & Yamamoto, A. (2015) · Cytotherapy · doi:10.1016/j.jcyt.2015.04.009 · Cited by 104
Molecular profiling of dilated cardiomyopathy that progresses to heart failure
Burke, M. A., Chang, S., Wakimoto, H., Gorham, J. M., Conner, D. A., Christodoulou, D. C., Parfenov, M. G., DePalma, S. R., Eminaga, S., Konno, T., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.86898 · Cited by 95
Osawa, Y., Oboki, K., Imamura, J., Kojika, E., Hayashi, Y., Hishima, T., Saibara, T., Shibasaki, F., Kohara, M., & Kimura, K. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.10.010 · Cited by 94
Marriott, S., Baskir, R. S., Gaskill, C. F., Menon, S., Carrier, E. J., Williams, J. A., Talati, M. H., Helm, K. M., Alford, C. E., Kropski, J. A., et al. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00114.2014 · Cited by 99
Hu, B., & Phan, S. H. (2013) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32835b1352 · Cited by 98
Fibroblast-mediated pathways in cardiac hypertrophy
Fujiu, K., & Nagai, R. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.01.013 · Cited by 110
Therapeutic targets in the Wnt signaling pathway: Feasibility of targeting TNIK in colorectal cancer
Masuda, M., Sawa, M., & Yamada, T. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.10.009 · Cited by 89
Lin, H., Angeli, M., Chung, K. J., Ejimadu, C., Rosa, A. R., & Lee, T. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00137.2016 · Cited by 97
A Beginner’s Introduction to Skin Stem Cells and Wound Healing
Garcia, D. D., Filipová, A., Veloz, I. G., & Martínez‐Fierro, M. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011030 · Cited by 110
“TGF-β also downregulates the Wnt-antagonist Dickkopf-1 (Dkk-1), thereby upregulating the Wnt/β-catenin signaling pathway [114].”
BackgroundZhang, L., Zhang, L., Huang, Z., Xing, R., Li, X., Yin, S., Mao, J., Zhang, N., Mei, W., Ding, L., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6326517 · Cited by 91
CEMIP (KIAA1199) induces a fibrosis-like process in osteoarthritic chondrocytes
Deroyer, C., Charlier, E., Neuville, S., Malaise, O., Gillet, P., Kurth, W., Chariot, A., Malaise, M., & de Seny, D. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1377-8 · Cited by 96
An Immune Dysregulation in MPN
Barosi, G. (2014) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-014-0227-0 · Cited by 96
Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signalling
Distler, A., Deloch, L., Huang, J., Dees, C., Lin, N.-Y., Palumbo-Zerr, K., Beyer, C., Weidemann, A., Distler, O., Schett, G., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202275 · Cited by 89
“Injections of viruses encoding for LacZ (Ad-LacZ) served as controls.(10) 15”
BackgroundMethodInfluentialSelf-citationMaruta, H., Yoshimura, Y., Araki, A., Kimoto, M., Takahashi, Y., & Yamashita, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158055 · Cited by 97
Ng-Blichfeldt, J.-P., de Jong, T. V., Kortekaas, R. K., Wu, X., Lindner, M., Guryev, V., Hiemstra, P. S., Stolk, J. N., Königshoff, M., & Gosens, R. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00400.2018 · Cited by 97
“14 Aberrant Wnt/β-catenin pathway activation contributes to TGF-β-induced fibrotic remodeling in 439 numerous adult fibrotic diseases including IPF (1, 15, 25, 30).”
BackgroundCai, J., Liu, Z., Huang, X., Shu, S., Hu, X., Zheng, M., Tang, C., Liu, Y., Chen, G., Sun, L., et al. (2020) · Kidney International · doi:10.1016/j.kint.2019.08.028 · Cited by 87
The Many Faces of Matrix Metalloproteinase-7 in Kidney Diseases
Liu, Z., Tan, R. J., & Liu, Y. (2020) · Biomolecules · doi:10.3390/biom10060960 · Cited by 94
“TGF-β also inhibits Dickkopf-1, an antagonist of Wnt, and potentiates the activity of β-catenin, thereby activating Wnt/β-catenin signaling [40,41].”
BackgroundEvolution of placental invasion and cancer metastasis are causally linked
Gupta, K., Afzal, J. M., Maziarz, J. D., Hamidzadeh, A., Liang, C., Erkenbrack, E. M., Kim, H. N., Häeger, J.-D., Pfarrer, C. D., Hoang, T. S., et al. (2019) · Nature Ecology & Evolution · doi:10.1038/s41559-019-1046-4 · Cited by 95
Targeted alveolar regeneration with Frizzled-specific agonists
Nabhan, A. N., Webster, J. D., Adams, J., Blazer, L. L., Everrett, C., Eidenschenk, C., Arlantico, A., Fleming, I., Brightbill, H. D., Wolters, P. J., et al. (2023) · Cell · doi:10.1016/j.cell.2023.05.022 · Cited by 88
“In this setting, CHIR acts not only on AT2 cells to promote their proliferation, but also on fibroblasts to induce pro-fibrotic factors such as TGF-b.28,59 TGF-b is Figure 4.”
A Glimpse of the Pathogenetic Mechanisms of Wnt/ β -Catenin Signaling in Diabetic Nephropathy
Xiao, L., Wang, M., Yang, S., Liu, F., & Sun, L. (2013) · BioMed Research International · doi:10.1155/2013/987064 · Cited by 93
Promising targets for therapy of osteoarthritis: a review on the Wnt and TGF-β signalling pathways
Cherifi, C., Monteagudo, S., & Lories, R. J. U. (2021) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x211006959 · Cited by 98
TGF‐β‐induced profibrotic signaling is regulated in part by the WNT receptor Frizzled‐8
Spanjer, A. I. R., Baarsma, H. A., Oostenbrink, L. M., Jansen, S. R., Kuipers, C. C., Lindner, M., Postma, D. S., Meurs, H., Heijink, I. H., Gosens, R., et al. (2016) · The FASEB Journal · doi:10.1096/fj.201500129 · Cited by 79
Endothelial‐to‐mesenchymal transition induced by W nt 3a in keloid pathogenesis
Lee, W. J., Park, J. H., Shin, J. U., Noh, H., Lew, D. H., Yang, W. I., Yun, C., Lee, D. W., & Lee, J. H. (2015) · Wound Repair and Regeneration · doi:10.1111/wrr.12300 · Cited by 82
Vaira, V., Roncoroni, L., Barisani, D., Gaudioso, G., Bòsari, S., Bulfamante, G., Doneda, L., Conte, D., Tomba, C., Bardella, M. T., et al. (2013) · Clinical Science · doi:10.1042/cs20130248 · Cited by 86
S100A4 amplifies TGF-β-induced fibroblast activation in systemic sclerosis
Tomčík, M., Palumbo‐Zerr, K., Zerr, P., Avouac, J., Dees, C., Šumová, B., Distler, A., Beyer, C., Cerezo, L. A., Bečvář, R., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204516 · Cited by 85
Self-citationAdvanced Role of Hippo Signaling in Endometrial Fibrosis: Implications for Intrauterine Adhesion
Zhu, H.-Y., Ge, T., Pan, Y., & Zhang, S. (2017) · Chinese Medical Journal · doi:10.4103/0366-6999.218013 · Cited by 88
“[47] Silence or inhibition of β‐catenin attenuates TGF‐β‐induced fibrotic process[48] and decreases the expression of α‐SMA, collagen I, and CTGF in endometriotic stromal cells.”
BackgroundThe Wnt Signaling Pathway in Diabetic Nephropathy
Wang, H., Zhang, R., Wu, X., Chen, Y., Ji, W., Wang, J., Zhang, Y., Xia, Y., Tang, Y., & Yuan, J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.701547 · Cited by 87
“TGFβ activatesWnt signals by downregulating the production of DKK-1 (Akhmetshina et al., 2012).”
BackgroundInfluentialGiacomelli, C., Piccarducci, R., Marchetti, L., Romei, C., & Martini, C. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114812 · Cited by 83
“TGF-β has been also related to EMT due to its crosstalk with the canonical Wnt/β-catenin pathway [59].”
Managing Sarcopenia and Its Related-Fractures to Improve Quality of Life in Geriatric Populations
Hida, T. (2014) · Aging and Disease · doi:10.14336/ad.2014.0500226 · Cited by 76
“J Bone Miner Res, 25: 513-519 [3] Akhmetshina A, Palumbo K, Dees C, Bergmann C, Venalis P, Zerr P, et al.”
BackgroundWei, J., Zhu, H., Komura, K., Lord, G., Tomčík, M., Wang, W., Doniparthi, S., Tamaki, Z., Hinchcliff, M., Distler, J. H. W., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202716 · Cited by 84
Self-citationThe Hippo-Salvador signaling pathway regulates renal tubulointerstitial fibrosis
Seo, E., Kim, W.-Y., Hur, J., Kim, H., Nam, S. A., Choi, A., Kim, Y.-M., Park, S. H., Chung, C., Kim, J., et al. (2016) · Scientific Reports · doi:10.1038/srep31931 · Cited by 74
Andrianifahanana, M., Hernandez, D. M., Yin, X., Kang, J., Jung, M., Wang, Y., Yi, E. S., Roden, A. C., Limper, A. H., & Leof, E. B. (2016) · The FASEB Journal · doi:10.1096/fj.201600428r · Cited by 74
Palevski, D., Levin‐Kotler, L., Kain, D., Naftali‐Shani, N., Landa, N., Ben‐Mordechai, T., Konfino, T., Holbová, R., Molotski, N., Rosin‐Arbesfeld, R., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004387 · Cited by 81
“19 In addition, Wnt/b-catenin signaling promotes cardiac fibrosis by inducing the transition of endothelial and epicardial cells to a mesenchymal state,(16,20,21) differentiation of fibroblasts into myofibroblasts, and collagen production.(22,23)”
BackgroundFatty acid synthase is required for profibrotic TGF‐β signaling
Jung, M., Kang, J. H., Hernandez, D. M., Yin, X., Andrianifahanana, M., Wang, Y., González-Guerrico, A. M., LIMPER, A. H., & Leof, E. B. (2018) · The FASEB Journal · doi:10.1096/fj.201701187r · Cited by 78
Singh, S. P., Tao, S., Fields, T. A., Webb, S., Harris, R. C., & Rao, R. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.020511 · Cited by 81
“In addition to SMAD, the Wnt signaling pathway also mediates the effects of TGF-β1 (Akhmetshina et al., 2012; Zhou, 2011).”
Choi, S., Yoon, M., & Choi, K. (2021) · Advances in Wound Care · doi:10.1089/wound.2020.1284 · Cited by 80
Zhang, P., Cai, Y., Soofi, A. A., & Dressler, G. R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.357202 · Cited by 76
“Recent evidence implied that Wnt signaling, especially the canonical Wnt/ -catenin pathway, was involved in EMT- and TGF- -mediated fibrosis (19, 25, 45, 46).”
BackgroundTryptophan metabolites kynurenine and serotonin regulate fibroblast activation and fibrosis
Dolivo, D., Larson, S. A., & Dominko, T. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2880-2 · Cited by 73
Dees, C., Beyer, C., Distler, A., Soare, A., Zhang, Y., Palumbo‐Zerr, K., Distler, O., Schett, G. A., Sandner, P., & Distler, J. H. W. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206809 · Cited by 72
Self-citationMechanical and Immunological Regulation in Wound Healing and Skin Reconstruction
Kimura, S., & Tsuji, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115474 · Cited by 79
Zhai, X., Yan, K., Fan, J., Niu, M., Zhou, Q., Zhou, Y., Chen, H., & Zhou, Y. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12114 · Cited by 69
“While we were preparing this article, Akhmetshina and his colleagues found that b-catenin activity was correlated with transforming growth factor-b1(TGF-b1)-induced dermal fibrosis (Akhmetshina et al., 2012).”
MethodCanonical Wnt signalling as a key regulator of fibrogenesis – implications for targeted therapies?
Dees, C., & Distler, J. H. W. (2013) · Experimental Dermatology · doi:10.1111/exd.12255 · Cited by 67
Self-citationCanonical Wnt signaling in systemic sclerosis
Bergmann, C., & Distler, J. H. W. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2015.154 · Cited by 74
Self-citationLiu, L., Chen, G., Chen, T., Shi, W., Hu, H., Song, K., Huang, R., Cai, H., & He, Y. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01990-3 · Cited by 68
The role of Wnt signaling in skin fibrosis
Griffin, M., Huber, J., Fahy, E. J., Quarto, N., & Longaker, M. T. (2021) · Medicinal Research Reviews · doi:10.1002/med.21853 · Cited by 73
“In support of these findings, topical application of the Wnt antagonist Dkk1 prevented skin fibrosis through TGF‐β signaling.(47) The fibroblast‐to‐ myofibroblast transition is a key event during wound fibrosis.”
BackgroundMethodResultInfluentialDevelopmental origins and functions of stromal cells in the normal and diseased mammalian kidney
Li, W., Hartwig, S., & Rosenblum, N. D. (2014) · Developmental Dynamics · doi:10.1002/dvdy.24134 · Cited by 70
“These results are suggestive of a role for Wnt/b-catenin signaling in fibrotic disease, consistent with other reports (Lam and Gottardi, 2011; Akhmetshina et al., 2012).”
ResultJeffries, M. A., & Sawalha, A. H. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2015.994507 · Cited by 77
“One such pathway, Wnt, contributes to skin fibrosis in SSc patients [102].”
BackgroundEnzo, M. V., Rastrelli, M., Rossi, C. R., Hladnik, U., & Segat, D. (2015) · Molecular and Cellular Therapies · doi:10.1186/s40591-015-0038-2 · Cited by 72
“Subsequently, phosphorylation of APC by CK1α and GSK3β leads to an increased AXIN -catenin APC GSK3 CK1 P P P P TRCP Proteolysis mediated by ubiquination LRP5/6 FZD DVL TCF/LEF nucleus WNT SFRPsDKK WIF SB216763 LiCl Gene target A Figure 1 The canonical Wnt/β-catenin pathway.”
InfluentialMichel, L., Reygagne, P., Benech, P., Jean‐Louis, F., Scalvino, S. A., So, S. L. K., Hamidou, Z., Bianovici, S., Pouch, J., Ducos, B., et al. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15577 · Cited by 77
Role of microRNA in the pathogenesis of systemic sclerosis tissue fibrosis and vasculopathy
Henry, T. W., Mendoza, F. A., & Jiménez, S. A. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.102396 · Cited by 73
Pulmonary activation of vitamin D3 and preventive effect against interstitial pneumonia
Tsujino, I., Ushikoshi‐Nakayama, R., Yamazaki, T., Matsumoto, N., & Saito, I. (2019) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.19-48 · Cited by 81
Guo, R., Merkel, A. R., Sterling, J. A., Davidson, J. M., & Guelcher, S. A. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.09.005 · Cited by 66
“Mechanical forces experienced by dermal fibroblasts, either through applied strain [10] or a stiff extra cellular substrate [11], activate the Wnt/ β-catenin signaling pathway, which promotes the fibr oblast-myofibroblast transition [12, 13] and is required for TGFβ mediated fibrosis [14-16].”
BackgroundNoncanonical Wnt Signaling Promotes Myofibroblast Differentiation in Pulmonary Fibrosis
Liu, T., Santos, F. G. D. L., Hirsch, M., Wu, Z., & Phan, S. H. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0499oc · Cited by 72
“On the other hand, participation ofWnt/b-catenin in induction of myofibroblast differentiation is expected to delay resolution and contribute to chronic lungpathologies, includingfibrosis (12, 16, 23, 24).”
BackgroundROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling
Pinho, A. V., Van Bulck, M., Chantrill, L., Arshi, M., Sklyarova, T., Herrmann, D., Vennin, C., Gallego-Ortega, D., Mawson, A., Giry-Laterriere, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07497-z · Cited by 64
Guo, X., Sunil, C., Adeyanju, O. A., Parker, A., Huang, S. K., Ikebe, M., Tucker, T. A., Idell, S., & Qian, G. (2022) · Scientific Reports · doi:10.1038/s41598-022-07044-3 · Cited by 69
Targeting the Wnt signaling pathway in colorectal cancer
Sawa, M., Masuda, M., & Yamada, T. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1098619 · Cited by 73
“TGF-b is the major cytokine that triggers EMT by activating several pathways including the Wnt/b-catenin signaling pathway [69-71].”
BackgroundTGF-β1 epigenetically modifies Thy-1 expression in primary lung fibroblasts
Neveu, W. A., Mills, S. T., Staitieh, B. S., & Sueblinvong, V. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00086.2015 · Cited by 66
“Other cell signaling pathways have also been implicated, including activation of Smad and non-Smad pathways (such as canonical Wnt, Erk, JNK/p38, small GTPase, and PI3K/Akt)(1, 39).”
BackgroundZhang, Y., Dees, C., Beyer, C., Lin, N.-Y., Distler, A., Zerr, P., Palumbo, K., Susok, L., Kreuter, A., Distler, O., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204256 · Cited by 64
Self-citationBanerjee, J., Shi, Y., & Azevedo, H. S. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.05.020 · Cited by 74
In the Wnt-er of life: Wnt signalling in melanoma and ageing
Kaur, A., Webster, M. R., & Weeraratna, A. T. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.332 · Cited by 66
“Whereas DKK1 inhibits b-catenin-mediated signalling in normal dermal fibroblasts, as do other DKK family member proteins, particularly DKK3, which acts on melanoma cells (Akhmetshina et al, 2012).”
Backgroundvan de Vlekkert, D., Demmers, J., Nguyen, X.-X., Campos, Y., Machado, E., Annunziata, I., Hu, H., Gomero, E., Qiu, X., Bongiovanni, A., et al. (2019) · Science Advances · doi:10.1126/sciadv.aav3270 · Cited by 62
Worrell, J. C., & O’Reilly, S. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102526 · Cited by 64
Cellular crosstalk in fibrosis: Insights into macrophage and fibroblast dynamics
Froom, Z. S. C. S., Callaghan, N. I., & Huyer, L. D. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110203 · Cited by 70
Reich, N., Tomcik, M., Zerr, P., Lang, V., Dees, C., Avouac, J., Palumbo, K., Horn, A., Akhmetshina, A., Beyer, C., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200412 · Cited by 60
Self-citationThalji, N. M., Hagler, M. A., Zhang, H., Casaclang‐Verzosa, G., Nair, A., Suri, R. M., & Miller, J. D. (2015) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.114.000921 · Cited by 63
“This is in keeping with prior evidence suggesting a key interaction between TGF-β and Wnt signaling pathways in promoting fibrosis in other tissues.(35) Previous data have shown that TGF-β and BMP signaling are also capable of inducing transcription of Runx2, as well as promoting its activity as a transcription factor.”
Mechanotransduction in Skin Inflammation
Shutova, M. S., & Boehncke, W. (2022) · Cells · doi:10.3390/cells11132026 · Cited by 66
Thrown off balance: the effect of antenatal inflammation on the developing lung and immune system
Kunzmann, S., Collins, J. J. P., Kuypers, E., & Kramer, B. W. W. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.01.008 · Cited by 67
Sun, L., Zhang, X., Wu, S., Liu, Y., Guerrero‐Juarez, C. F., Liu, W., Huang, J., Yao, Q., Yin, M., Li, J., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112647 · Cited by 61
Integration of microRNA and mRNA expression profiles in the skin of systemic sclerosis patients
Zhou, B., Zuo, X. X., Li, Y. S., Gao, S. M., Dai, X. D., Zhu, H. L., & Luo, H. (2017) · Scientific Reports · doi:10.1038/srep42899 · Cited by 61
EZH2‐mediated repression of Dkk1 promotes hepatic stellate cell activation and hepatic fibrosis
Yang, Y., Chen, X., Li, W., Wu, X., Huang, C., Xie, J., Zhao, Y., Meng, X., & Li, J. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13153 · Cited by 62
“These observations indicate that activation of Wnt/b-catenin pathway significantly contributes to the development of hepatic fibrosis [7, 8].”
BackgroundRuaro, B., Casabella, A., Paolino, S., Pizzorni, C., Ghio, M., Seriolo, C., Molfetta, L., Odetti, P. R., Smith, V. M., & Cutolo, M. (2018) · Clinical Rheumatology · doi:10.1007/s10067-018-4322-9 · Cited by 61
Endothelial-to-mesenchymal transition in systemic sclerosis
Benedetto, P. D., Ruscitti, P., Berardicurti, O., Vomero, M., Navarini, L., Dolo, V., Cipriani, P., & Giacomelli, R. (2021) · Clinical & Experimental Immunology · doi:10.1111/cei.13599 · Cited by 62
Mannino, F., Imbesi, C., Bitto, A., Minutoli, L., Squadrito, F., D’Angelo, T., Booz, C., Pallio, G., & Irrera, N. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114666 · Cited by 60
The Dishevelled-binding protein CXXC5 negatively regulates cutaneous wound healing
Lee, S.-H., Kim, M.-Y., Kim, H.-Y., Lee, Y.-M., Kim, H., Nam, K. A., Roh, M. R., Min, D. S., Chung, K. Y., & Choi, K.-Y. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141601 · Cited by 60
“The Wnt/-catenin pathway is also aberrantly activated in certain human fibrotic diseases, which are characterized by increased nuclear accumulation of -catenin (Sato, 2006; Akhmetshina et al., 2012).”
BackgroundMethodInfluentialZhang, Y., Liang, R., Chen, C.-W., Mallano, T., Dees, C., Distler, A., Reich, A., Bergmann, C., Ramming, A., Gelse, K., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210911 · Cited by 64
Self-citationThermodynamic Aspects and Reprogramming Cellular Energy Metabolism during the Fibrosis Process
Vallée, A., Lecarpentier, Y., & Vallée, J.-N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122537 · Cited by 63
“Moreover, activation of TGF-β also stimulates the WNT pathway by inhibiting dickkopf-related protein 1 (DKK1) expression, an inhibitor of WNT/β-catenin pathway [152].”
BackgroundCardioprotective actions of relaxin
Martin, B., Romero, G. G., & Salama, G. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.12.016 · Cited by 62
Molecular mechanisms of sacubitril/valsartan in cardiac remodeling
Mustafa, N. H., Jalil, J., Zainalabidin, S., Saleh, M. S. M., Asmadi, A. Y., & Kamisah, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.892460 · Cited by 65
“There is considerable evidence that shows that the secreted frizzled-related protein 1 (sFRP-1)/Wnt/β-catenin signaling pathway plays a role in TGF-β-mediated fibrosis in cardiac remodeling (Akhmetshina et al., 2012; McMurray et al., 2014).”
BackgroundOwen, J. S., Clayton, A., & Pearson, H. B. (2022) · Biomolecules · doi:10.3390/biom13010067 · Cited by 66
“Recently, Wnt signaling has been reported to mediate fate specification of fibroblast progenitors into numerous lineages, including fibroblasts in the skin [33], and tumor growth factor β (TGFβ)-Wnt signaling cross-talk has been shown to regulate myofibroblast activation in skin by reducing the Wnt antagonist Dikkopf-…”
BackgroundBastakoty, D. (2016) · Cell Stem cells and Regenerative Medicine · doi:10.16966/2472-6990.111 · Cited by 59
Lafyatis, R., Mantero, J. C., Gordon, J., Kishore, N., Carns, M., Dittrich, H., Spiera, R., Simms, R. W., & Varga, J. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.06.032 · Cited by 59
Metadata
- Authors
- Akhmetshina, A., Palumbo, K., Dees, C., Bergmann, C., Venalis, P., Zerr, P., Horn, A., Kireva, T., Beyer, C., Zwerina, J., Schneider, H., Sadowski, A., Riener, M.-O., MacDougald, O. A., Distler, O., Schett, G., & Distler, J. H. W.
- Affiliations
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- University of Michigan (US)
- University Hospital Zurich (CH)
- Corresponding author
- Distler, Jörg H.W.
- ORCID
- Venue
- Nature Communications
- Published
- 2012-03-13
- Volume
- 3
- Issue
- 1
- Pages
- 735-735
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC3316881
- OpenAlex
- W2059114286
- Cited by
- 843
- References
- 61
- Citations by year
- 2026: 45 · 2025: 61 · 2024: 68 · 2023: 57 · 2022: 74 · 2021: 58 · 2020: 67 · 2019: 60 · 2018: 59 · 2017: 65 · 2016: 59 · 2015: 54 · 2014: 57 · 2013: 43 · 2012: 16
- FWCI
- 21.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/3.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/3.0/ (vor)
- Locations
- Nature Communications (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Bundesministerium für Bildung und Forschung (01EC1002D)
- National Institutes of Health (DK62876)
- National Institute of Diabetes and Digestive and Kidney Diseases (R24DK092759, DK-51563, N02 DK062876, DK92759, R01DK051563, R01DK062876, P30DK020572)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- Wnt/β-catenin signaling, TGF-beta signaling, fibrosis, DKK1, p38 MAPK, fibroblast activation, skin fibrosis, TGF-beta type I receptor, extracellular matrix synthesis, fibrotic diseases, pathway interactions
- MeSH terms
- Adult, Animals, Cells, Cultured, Extracellular Matrix, Female, Fibrosis, Humans, Male, Mice, Transgenic, Middle Aged, Transforming Growth Factor beta, Receptors, Transforming Growth Factor beta, RNA Interference, RNA, Small Interfering, Intercellular Signaling Peptides and Proteins, p38 Mitogen-Activated Protein Kinases, Wnt Proteins, Mice, Wnt Signaling Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.